Alterations in tumour suppressor gene p53 correlate with inhibition of thrombospondin-1 gene expression in colon cancer cells

Virchows Archiv

Volumn 433, Issue 5, 1998, Pages 415-418

  Tokunaga, Tetsuji ^a   Nakamura, Masato ^a   Oshika, Yoshiro ^a   Tsuchida, Takashi ^a   Kazuno, Michitake ^a   Fukushima, Yoshitaka ^a   Kawai, Kenji ^a   Abe, Yoshiyuki ^a   Kijima, Hiroshi ^a   Yamazaki, Hitoshi ^a   Tamaoki, Norikazu ^a   Ueyama, Yoshito ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

Colon cancer; p53; Thrombospondin 1

Indexed keywords

PROTEIN P53; THROMBOSPONDIN 1;

ADULT; ANGIOGENESIS; ARTICLE; CANCER CELL; COLON CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; NORTHERN BLOTTING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; AGED; BLOTTING, NORTHERN; COLONIC NEOPLASMS; DNA PRIMERS; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MUTATION; THROMBOSPONDIN 1; TUMOR SUPPRESSOR PROTEIN P53;

EID: 14444282619     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050268     Document Type: Article

References (39)

1. Baenziger NL, Brodie GN, Majerus PW (1972) Isolation and properties of a thrombin sensitive protein of human platelets. J Biol Chem 247:2723-2731
2. Bell SM, Scott N, Cross D, Sagar P, Lewis FA, Blair GE, Taylor GR, Dixon MF, Quirke P (1993) Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology 104:57-64
3. Clezardin P, Frappart L, Clerget M, Pechoux C, Delmas PD (1993) Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast. Cancer Res 53:1421-1430
4. Dameron KM, Volpert OV, Tainsky MA, Bouck N (1994) Control of angiogenesis in fibloblasts by p53 regulation of thrombospondin-1. Science 265:1582-1584
5. Dix B, Robbins P, Carrello S, House A, Iacopetta B (1994) Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. Br J Cancer 70:585-590
6. Gehron RP, Young MF, Fisher LW, McClain TD (1989) Thrombospondin is an osteoblast-derived component of mineralized extracellular matrix. J Cell Biol 108:719-727
7. Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, Bouck NP (1990) A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 87:6624-6628
8. Greenblant MS, Bennett WP, Hollstein M, Harris C (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878
9. Grossfeld GD, SHI SR, Ginsberg DA, Rich KA, Skinner DG, Taylor CR, Cote RJ (1996) Immunohistochemical detection of thrombospondin-1 in formalin-fixed, paraffin-embedded tissue. J Histochem Cytochem 44:761-766
10. Grossfeld GD, Ginsberg DA, Stein JP, Bochner BH, Esrig D, Groshen S, Dunn M, Nichols PW, Taylor CR, Skinner DG, Cote RJ (1997) Thrombospondin-1 expression in bladder cancer: association with P53 alterations, tumor angiogenesis, and tumor progression. J Natl Cancer Inst 89:219-227
11. Hamelin R, Laurent-Puig P, Olschwang S Jego N, Asselain B, Remvikos Y, Girodet J, Salmon RJ, Thomas G (1994) Association of p53 mutations with short survival in colorectal cancer. Gastroenterology 106:42-48
12. Hollstein M, Sidransky D, Vogelstein B, Harris C (1991) p53 mutations in human cancers. Science 253:49-53
13. Iruela ML, Bornstein P, Sage H (1991) Thrombospondin exerts an anti-angiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci USA 88:5026-5030
14. Itoh J, Osamura RY, Watanabe K (1992) Subcellular visualization of light microscopic specimens by laser scanning microscopy and computer analysis: a new application of image analysis. J Histochem Cytochem 40:955-967
15. Jaffe EA, Ruggiero JT, Leung LLK, Doyle MJ, McKeon PJ, Mosher DF (1983) Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix. Proc Natl Acad Sci USA 80:998-1002
16. Jaffe EA, Ruggiero JT, Falcon DJ (1985) Monocytes and macrophages synthesize and secrete thrombospondin. Blood 65: 79-84
17. Lawler J (1986) The structural and functional properties of thrombospondin. Blood 67:112-123
18. Majack RA, Cook S, Bornstein P (1985) Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells. J Cell Biol 101:1059-1070
19. Mukhopadhyay D, Tsiokas L, Sukhatme VP (1995) Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res 55: 6161-6165
20. Neng-hua G, Krutzsch HC, Inman JK, Roberts DD (1997) Thrombospondin 1 and type 1 repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Cancer Res 57:1735-1742
21. Nicosia RF, Tuszynski GP (1994) Matrix-bound thrombospondin promotes angiogenesis in vitro. J Cell Biol 124:183-193
22. O'Shea KS, Dixit VM (1988) Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo. J Cell Biol 107:2737-2748
23. O'Shea KS, Liu LHJ, Kinnunen LH, Dixit VM (1990) Role of the extracellular matrix protein thrombospondin in the early development of the mouse embryo. J Cell Biol 111:2713-2723
24. Qian X, Tuszynski GP (1996) Expression of thrombospondin-1 in cancer: a role in tumor progression. Proc Soc Exp Biol Med 212:199-207
25. Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasaws S, Sasazuki T, Kerbel RS (1995) Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 55:4575-4580
26. Roberts DD, Sherwood JA, Ginsburg V (1987) Platelet thrombospondin mediates attachment and spreading of human melanoma cells. J Cell Biol 104:131-139
27. Sage EH, Bornstein P (1991) Extracellular proteins that modulate cell-matrix interactions. J Biol Chem 266:14831-14834
28. Siemeister G, Weindel K, Mohrs K, Barleon B, Martiny-Baron G, Marme D (1996) Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res 56:2299-2301
29. Smith DR, Ji CY, Goh HS (1996) Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas. Br J Cancer 74:216-223
30. Stellmach V, Volpert OV, Crawford SE, Lawler J, Hynes RO, Bouck N (1996) Tumour suppresser genes and angiogenesis: the role of TP53 in fibloblasts. Eur J Cancer 14:2394-2400
31. Taraboletti G, Roberts DD, Liotta LA (1987) Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains. J Cell Biol 105:2409-2415
32. Taraboletti G, Roberts DD, Liotta LA, Giavazzi R (1990) Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J Cell Biol 111:765-772
33. Tokunaga T, Oshika Y, Abe Y, Ozeki Y, Sadahiro S, Kijima H, Tsuchida T, Yamazaki H, Ueyama Y, Tamaoki N, Nakamura M (1998) Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br J Cancer 77:998-1002
34. Tuszynski GP, Nicosia RF (1994) Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine receptor in human breast carcinoma. Lab Invest 70: 228-233
35. Varani J, Dixit VM, Fliegel SE, Mckeever PE, Carey TE (1986) Thrombospondin-induced attachment and spreading of human squamous carcinoma cells. Exp Cell Res 167:376-390
36. Vogelstein B, Fearson ER, Hamilton SR Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL (1988) Genetic alterations during colorectal tumor development. N Engl J Med 319:525-532
37. Volpert OV, Dameron KM, Bouck N (1997) Sequential development of an angiogenic phenotype by human fibloblasts progressing to tumorigenicity in vivo. Oncogene 14:1495-1502
38. Weinstat DL, Zabrenetzky VS, VanHoutte K, Frazier WA, Roberts DD, Steeg PS (1994) Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res 54:6504-6511
39. Zabrenetzky V, Harris CC, Steeg PS, Roberts DD (1994) Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung, and breast carcinoma cell lines. Int J Cancer 59:191-195